Allianz Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $765K | Buy |
12,100
+6,000
| +98% | +$379K | ﹤0.01% | 1305 |
|
|
2025
Q1 | $323K | Hold |
6,100
| – | – | ﹤0.01% | 1547 |
|
|
2024
Q4 | $341K | Buy |
6,100
+2,000
| +49% | +$112K | ﹤0.01% | 1505 |
|
|
2024
Q3 | $215K | Buy |
+4,100
| New | +$215K | ﹤0.01% | 1605 |
|
|
2024
Q2 | – | Sell |
-7,400
| Closed | -$321K | – | 1732 |
|
|
2024
Q1 | $321K | Sell |
7,400
-4,500
| -38% | -$195K | ﹤0.01% | 1517 |
|
|
2023
Q4 | $547K | Hold |
11,900
| – | – | ﹤0.01% | 1386 |
|
|
2023
Q3 | $273K | Hold |
11,900
| – | – | ﹤0.01% | 1572 |
|
|
2023
Q2 | $196K | Hold |
11,900
| – | – | ﹤0.01% | 1443 |
|
|
2023
Q1 | $212K | Hold |
11,900
| – | – | ﹤0.01% | 1552 |
|
|
2022
Q4 | $347K | Hold |
11,900
| – | – | ﹤0.01% | 1400 |
|
|
2022
Q3 | $292K | Buy |
+11,900
| New | +$292K | ﹤0.01% | 1378 |
|